Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Clinical trial NCT05517421 · COMPLETED

Trial details

NCT number: NCT05517421
Sponsor: Immunovant Sciences GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Eye Disease

Start date: 2022-11-23
Primary completion: 2025-11-02
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.